NSEGeneral Updates4d ago · 18 Sept 2026, 10:27 am
General Updates
Concord Biotech Limited · CONCORDBIO
✦ AI SummaryRegulatory
Concord Biotech Limited has announced that the USFDA has successfully completed an inspection at its Valthera Formulation Facility with one minor procedural observation unrelated to GMP. The company will submit a comprehensive response within the stipulated timeline.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Intimation of Outcome of U.S. Food and Drug Administration (USFDA) Inspection at Unit II Valthera Formulation Facility of the Company